DCH

DCH remains in a longer-term downtrend and is structurally oversold, granting permission for a tactical mean-reversion flip to the long side despite persistent lower highs and lower lows. Execution should be deferred until price shows clear acceptance above the short-term EMAs, focusing on pullbacks into those moving averages. The medium-term tradable side is bullish under the mean-reversion override, but caution is warranted given ongoing supply dominance and the risk of further downside momentum.

• ↑$100M cost synergies from Dowlais acquisition targeted by year-end.
• ↑Q1 revenue of $2.4B drove 2026 guidance to $10.3–10.8B.
• ↓Debt leverage of 2.65x heightens refinancing challenges if rates rise.